294: Pharma goes to Washington, Alnylam's future, & Gilead's dealmaking
The Readout Loud
00:00
Unveiling of Letigo Biotherapeutics
The chapter discusses the unveiling of Letigo Biotherapeutics, a new biotech startup aiming to develop a non-opioid painkiller targeting the sodium channel NAV 1.8. They analyze the company's progress, clinical trials, and plan to launch a phase two trial in acute pain. The chapter highlights the emergence of a competitor in the field and the importance of having a backup molecule in the iterative process of drug development.
Transcript
Play full episode
